2 Drugs Show Promise Against Blood Cancers
Ibrutinib, obinutuzumab slowed progression of common leukemia, non-Hodgkin lymphomaContinue Reading
Ibrutinib, obinutuzumab slowed progression of common leukemia, non-Hodgkin lymphomaContinue Reading
Study finds effect seems to extend to people exposed to secondhand smoke, tooContinue Reading
These pests breed indoors and may be resistant to common pesticidesContinue Reading
Researcher says infants may be ‘finding their voice’Continue Reading
Researcher says infants may be ‘finding their voice’Continue Reading
Finding might one day help doctors better choose patients to receive Keytruda, study saysContinue Reading
Patients given nivolumab reported fewer side effects, longer survival than those receiving usual chemo agentContinue Reading
Research suggests risk of nighttime breathing problem rises with severity of post-traumatic stress disorderContinue Reading
Study finds they are least spiritual generation in six decadesContinue Reading
LAM affects mostly women of child-bearing ageContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.